🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Background Treatment: Topical Corticosteroids

Found 6 matching trials

Study to Investigate the Efficacy and Safety of Dupilumab Administered With Topical Corticosteroids (TCS) in Participants ≥6 to <12 Years With Severe Atopic Dermatitis (AD)

PHASE3

The main objective of the trial is to demonstrate the efficacy of dupilumab...

Status

Completed

Location

Regeneron Research Site

Start Date

2017-11-17

Trial ID

NCT03345914

Treatments Being Tested

Dupilumab Matching Placebo Background Treatment: Topical Corticosteroids Background Treatment: Moisturizers

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor

PHASE3

This is a parallel group, Phase 3, multinational, multicenter, randomized, ...

Status

Active Not Recruiting

Location

University of Alabama at Birmingham- Site Number : 8401267

Start Date

2024-02-29

Trial ID

NCT06241118

Treatments Being Tested

Amlitelimab Placebo Topical corticosteroids Topical tacrolimus or pimecrolimus

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis on Background Topical Corticosteroids

PHASE3

This is a parallel group, Phase 3, multinational, multicenter, randomized, ...

Status

Completed

Location

Cahaba Dermatology & Skin Health Center- Site Number : 8401066

Start Date

2024-01-18

Trial ID

NCT06224348

Treatments Being Tested

Amlitelimab Placebo Topical corticosteroids Topical calcineurin inhibitors

Study to Assess the Safety of Dupilumab (REGN668/SAR231893) Administered Concomitantly With Topical Corticosteroids (TCS) in Patients With Moderate-to-severe Atopic Dermatitis (AD)

PHASE2

The purpose of this study was to assess the safety of Dupilumab administere...

Status

Completed

Location

Multiple Locations

Start Date

2012-07

Trial ID

NCT01639040

Treatments Being Tested

Dupilumab Placebo (for Dupilumab)Topical Corticosteroid (TCS)

Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (LIBERTY-PN PRIME)

PHASE3

Primary Objective: To demonstrate the efficacy of dupilumab on itch respon...

Status

Completed

Location

Investigational Site Number :8400011

Start Date

2019-12-12

Trial ID

NCT04183335

Treatments Being Tested

Dupilumab SAR231893 Placebo Moisturizers Low to medium potent topical corticosteroids Topical calcineurin inhibitors

Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (PRIME2)

PHASE3

Primary Objective: To demonstrate the efficacy of dupilumab on itch respon...

Status

Completed

Location

Investigational Site Number :8400054

Start Date

2020-01-16

Trial ID

NCT04202679

Treatments Being Tested

Dupilumab SAR231893 Placebo Moisturizers Low to medium potent topical corticosteroids Topical calcineurin inhibitors

Previous Next